hESC- and hiPSC-derived Schwann cells are molecularly comparable and functionally equivalent

Area of Science:

• Biomedical research
• Stem cell biology
• Neuroscience

Background:

• Developing human Schwann cell models is crucial for understanding peripheral nerve disorders.
• Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) are key cell sources, but their equivalence is debated.
• Schwann cells are vital for peripheral nerve myelination and regeneration.

Purpose of the Study:

• To compare the molecular and functional equivalence of Schwann cells derived from hESCs and hiPSCs.
• To validate a previously established differentiation protocol for both cell types.

Main Methods:

• RNA sequencing for transcriptome analysis.
• Antibody arrays for proteome profiling.
• In vivo assessment of nerve regeneration and function in an animal model.

Main Results:

• Minimal transcriptome differences were observed between hESC- and hiPSC-derived Schwann cells.
• Proteome analysis revealed insignificant differences between the two cell types.
• Both hESC- and hiPSC-derived Schwann cells demonstrated comparable efficacy in improving nerve regeneration and function.

Conclusions:

• Schwann cells derived from hESCs and hiPSCs using the described protocol are molecularly comparable.
• These cells exhibit functional equivalence, supporting their use in peripheral nerve injury and disease research.
• The findings contribute to the reliable use of hiPSCs as an alternative to hESCs in regenerative medicine.